Voices: Messages of Wisdom and Hope in the Face of Illness

NCT07381179 | Recruiting

• 2 other identifiers: 25-006417NCI-2026-00073
• Study Type: observational
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

This study may help doctors determine where patients and caregivers may need more support and identify ways to maintain patient and caregiver dignity while undergoing treatment.

Conditions

Malignant Solid Neoplasm; Hematopoietic and Lymphatic System Neoplasm

Outcome Measures

Primary Outcomes (1)

• Change in patient dignity impact

  Will assess patient dignity impact scale scores prior to and after completion of patient and caregiver recordings. The dignity impact scale (DIS) is a 7-item questionnaire with responses scaling from 1 (strongly disagree) to 5 (strongly agree). Higher scores indicate greater levels of dignity. Patient participants will complete the survey before and after their recordings as outlined in the schedule of events. Surveys will be completed digitally.

  Baseline (before and after recording)

Study Arms (1)

Observational

Patients and their caregivers complete an interview and survey on study. Patients also have their medical records reviewed on study.

Other: Non-Interventional Study

Interventions

Non-Interventional Study OTHER

Non-interventional study

Also known as: Non-Interventional Observational Study, Noninterventional (Observational) Study

Observational

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Diagnosis of chronic or progressive illness with a primary caregiver, should patient wish to involve one.

You may qualify if:

• Age ≥ 18 years
• Diagnosis of chronic or progressive illness with a primary caregiver, should patient wish to involve one
• Willing and able to participate in a semi-structured recording lasting approximately 60 minutes. Dyad recordings conducted for participants who elect to involve a caregiver
• Willing and able to participate in a single follow-up recording. Dyad follow up recordings conducted for participants who elect to involve a caregiver

You may not qualify if:

• Uncontrolled and/or intercurrent illness which limits participation in study recording
• Vulnerable populations: persons lacking capacity for understanding participation in this study

Sponsors & Collaborators

• Mayo Clinic: lead

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

RECRUITING

Related Links

• Mayo Clinic Clinical Trials

Study Officials

• Ugur Sener, MD

  Mayo Clinic

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Clinical Trials Referral Office

CONTACT

855-776-0015; mayocliniccancerstudies@mayo.edu

Susan Steinmetz

CONTACT

507-266-5280

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 23, 2026
• First Posted: February 2, 2026
• Study Start: November 13, 2025
• Primary Completion (Estimated): December 13, 2027
• Study Completion (Estimated): December 13, 2027
• Last Updated: February 2, 2026

Record last verified: 2026-01

Locations

US (1)